ViewRay to Participate in the 40th Annual J.P. Morgan Healthcare Conference
Ohio Pen/10151459

CLEVELAND, Dec. 23, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced its participation in the 40th Annual J.P. Morgan Healthcare Conference.

ViewRay's management is currently scheduled to present at 10:30 a.m. Eastern Time on Thursday, January 13, 2022.  An audio webcast of the Company's presentation will be available on the "Financial Events and Webinars" portion of ViewRay's investor website at

More on Ohio Pen
About ViewRay®

ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® MR-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

SOURCE ViewRay, Inc.
Filed Under: Business

Show All News | Report Violation


Latest on Ohio Pen